These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21998751)

  • 41. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
    Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
    Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1.
    Liu P; Xu B; Shen W; Zhu H; Wu W; Fu Y; Chen H; Dong H; Zhu Y; Miao K; Xu W; Li J
    Leukemia; 2012 Jun; 26(6):1293-300. PubMed ID: 22157808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Widespread B29 (CD79b) gene defects and loss of expression in chronic lymphocytic leukemia.
    Thompson AA; Do HN; Saxon A; Wall R
    Leuk Lymphoma; 1999 Feb; 32(5-6):561-9. PubMed ID: 10048429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells.
    Desch P; Asslaber D; Kern D; Schnidar H; Mangelberger D; Alinger B; Stoecher M; Hofbauer SW; Neureiter D; Tinhofer I; Aberger F; Hartmann TN; Greil R
    Oncogene; 2010 Sep; 29(35):4885-95. PubMed ID: 20603613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
    Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
    Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
    Johnson TA; Rassenti LZ; Kipps TJ
    J Immunol; 1997 Jan; 158(1):235-46. PubMed ID: 8977195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.
    Burger JA; Tsukada N; Burger M; Zvaifler NJ; Dell'Aquila M; Kipps TJ
    Blood; 2000 Oct; 96(8):2655-63. PubMed ID: 11023495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. All-trans-retinoic Acid differentially regulates proliferation of normal and leukemic B cells from different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G; Jadidi-Niaragh F; Amiri MM; Razavi SM; Saboor-Yaraghi AA; Shokri F
    Nutr Cancer; 2015; 67(2):285-91. PubMed ID: 25611428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoglobulin genes in chronic lymphocytic leukemia.
    Kipps TJ
    Blood Cells; 1993; 19(3):615-25; discussion 631-2. PubMed ID: 8018942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.
    Debant M; Burgos M; Hemon P; Buscaglia P; Fali T; Melayah S; Le Goux N; Vandier C; Potier-Cartereau M; Pers JO; Tempescul A; Berthou C; Bagacean C; Mignen O; Renaudineau Y
    J Immunother Cancer; 2019 Apr; 7(1):111. PubMed ID: 31014395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
    Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
    J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G; Jadidi-Niaragh F; Hojjat-Farsangi M; Asgarian-Omran H; Yousefi M; Tahmasebi F; Khoshnoodi J; Razavi SM; Saboor-Yaraghi AA; Rabbani H; Jeddi-Tehrani M; Shokri F
    Cytokine; 2013 Jun; 62(3):439-45. PubMed ID: 23579027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
    J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction.
    Sampalo A; Navas G; Medina F; Segundo C; Cámara C; Brieva JA
    Blood; 2000 Nov; 96(9):3168-74. PubMed ID: 11049999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
    Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.
    Li PP; Feng LL; Chen N; Ge XL; Lv X; Lu K; Ding M; Yuan D; Wang X
    Med Oncol; 2015 Feb; 32(2):479. PubMed ID: 25575438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
    Gilling CE; Mittal AK; Chaturvedi NK; Iqbal J; Aoun P; Bierman PJ; Bociek RG; Weisenburger DD; Joshi SS
    Br J Haematol; 2012 Jul; 158(2):216-231. PubMed ID: 22571278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.